Clorox (NYSE:CLX) Rating Lowered to “Strong Sell” at Zacks Research

Posted by Geri Gentry on Oct 31st, 2026

Clorox (NYSE:CLX – Get Free Report) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Thursday, Zacks reports. Zacks Research also issued estimates for Clorox’s Q1 2027 earnings at $0.91 EPS, Q2 2027 earnings at $1.30 EPS, Q3 2027 earnings at $1.56 EPS, Q4 2027 earnings at $1.77 EPS and FY2027 earnings at $5.53 EPS.

Other equities analysts also recently issued reports about the stock. Citigroup reduced their price objective on shares of Clorox from $97.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, October 14th. JPMorgan Chase & Co. lowered their target price on Clorox from $95.00 to $83.00 and set an “underweight” rating on the stock in a research report on Monday, October 19th. Evercore set a $99.00 target price on Clorox in a research report on Tuesday, August 4th. BNP Paribas Exane dropped their target price on Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a report on Monday, July 20th. Finally, Morgan Stanley reduced their price target on Clorox from $97.00 to $87.00 and set an “equal weight” rating for the company in a research report on Thursday, October 15th. Eleven analysts have rated the stock with a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of “Reduce” and an average price target of $93.57.

Check Out Our Latest Stock Report on Clorox

Clorox Stock Performance

Shares of CLX stock opened at $88.01 on Thursday. Clorox has a 12 month low of $79.12 and a 12 month high of $128.90. The company’s fifty day simple moving average is $88.61 and its 200-day simple moving average is $100.01. The firm has a market cap of $10.64 billion, a PE ratio of 18.26, a P/E/G ratio of 2.97 and a beta of 0.59. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80.

Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The business had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter last year, the firm earned $2.87 earnings per share. The firm’s revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Equities research analysts expect that Clorox will post 5.66 EPS for the current fiscal year.

Institutional Trading of Clorox

A number of large investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Clorox in the 2nd quarter valued at about $958,640,000. Bank of America Corp DE bought a new position in Clorox during the second quarter worth about $179,780,000. Royal Bank of Canada grew its holdings in Clorox by 20.1% during the first quarter. Royal Bank of Canada now owns 1,418,204 shares of the company’s stock worth $146,969,000 after purchasing an additional 237,301 shares during the period. ProShare Advisors LLC grew its holdings in Clorox by 6.3% during the third quarter. ProShare Advisors LLC now owns 1,737,891 shares of the company’s stock worth $140,787,000 after purchasing an additional 102,732 shares during the period. Finally, Bank of New York Mellon Corp increased its position in Clorox by 2.3% during the first quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company’s stock worth $132,670,000 after buying an additional 29,181 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

Positive Sentiment: New CEO appointed: Clorox named Fabian Garcia, a veteran consumer-products executive from Unilever, as CEO and chair effective January 5, 2027. His experience could help strengthen brand execution and support a turnaround after a comprehensive search. Matthew Shattock will resume his role as independent chair, while Linda Rendle is stepping down for health reasons. Clorox Appoints Fabian Garcia as CEO
Positive Sentiment: Potential earnings support: Analysts expect fiscal first-quarter 2027 results to benefit from product innovation, brand investments and the contribution from GOJO, the hand-care business acquired by Clorox. A stronger-than-expected report could provide a near-term catalyst. Clorox’s Q1 Earnings Coming Up: Key Insights for Investors
Neutral Sentiment: Valuation is being debated: Recent commentary suggests CLX may be fairly valued based on expected earnings, while the incoming CEO could make the stock appear inexpensive if he improves growth and profitability. Investors are likely to focus on guidance and the pace of recovery rather than valuation alone. Clorox Stock Looks About Right Based on Earnings
Negative Sentiment: Profitability and dividend risks remain: Higher costs, cautious consumer spending and potential pressure on margins may limit the benefit from innovation and GOJO. Analysts also view the dividend as facing a more difficult test, making cash flow and management’s outlook key issues in the earnings release. Clorox: An Easy Quarter Ahead, But a Harder Test for the Dividend

Clorox Company Profile

(Get Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.